Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 8FR6 | Q2N0S7 | Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 8G4M | Q2N0S7 | Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 8G4T | Q2N0S7 | Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 6MPG | Q2N0S6 | Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | A12V163-b.01 Light Chain, Envelope glycoprotein gp41, Envelope glycoprotein gp120, A12V163-b.01 Heavy Chain, PGT122 Heavy chain, PGT122 Light chain, VRC03 heavy chain, VRC03 Light chain |
| 6MU6 | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
| 6NNF | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to VRC01 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.5 Angstrom | |
| 6NNJ | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.1 Angstrom | Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain |
| 6OZ4 | Q2N0S6 | Crystal structure of broadly neutralizing antibody N49P6 Fab in complex with HIV-1 BG505 SOSIP.664 Env trimer ectodomain. | |
| 6U0N | Q2N0S6 | Asymmetrically open conformational state (Class II) of HIV-1 Env trimer BG505 SOSIP.664 in complex with sCD4 and E51 Fab | HIV-1 envelope glycoprotein gp120, T-cell surface glycoprotein CD4, E51 Fab heavy chain, E51 Fab light chain, HIV-1 envelope glycoprotein gp41 |
| 6VO0 | Q2N0S6 | BG505 SOSIP.v5.2 in complex with rabbit Fab 43A2 | 43A2 light chain, 43A2 heavy chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41 |
| 6X96 | Q2N0S6 | Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 10A fragment antigen binding variable domain | |
| 5V8M | Q2N0S6 | BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117 | gp120, gp41, antibody 3BNC117, heavy chain, antibody 3BNC117, light chain |
| 5W6D | Q2N0S6 | Crystal structure of BG505-SOSIP.v4.1-GT1-N137A in complex with Fabs 35022 and 9H/109L | |
| 6CUF | Q2N0S6 | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
| 6N1V | Q2N0S6 | Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | 17D4 Heavy chain, 17D4 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 Heavy chain, PGT122 Light chain, VRC03 Heavy chain, VRC03 Light chain |
| 6NF2 | Q2N0S6 | Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 | Envelope glycoprotein gp120, Envelope glycoprotein gp41, VRC03 Heavy Chain, VRC03 Light Chain, PGT122 Heavy Chain, PGT122 Light Chain, 0PV-c.01 Heavy Chain, 0PV-c.01 Light Chain |
| 6NM6 | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom | Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain |
| 7LL2 | Q2N0S6 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
| 7RAI | Q2N0S6 | Cryo-EM structure of M4008_N1 Fab in complex with BG505 DS-SOSIP.664 Env trimer | |
| 8TGO | Q2N0S6 | Crystal structure of the BG505 triple tandem trimer gp140 HIV-1 Env in complex with PGT124 and 35O22 | |
| 7LPN | Q2N0S6 | Cryo-EM structure of llama J3 VHH antibody in complex with HIV-1 Env BG505 DS-SOSIP.664 | |
| 6E5P | Q2N0S6 | Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antibody 2G12 bound to HIV-1 Env BG505 DS-SOSIP, which was also bound to CD4-binding site antibody VRC03 | |
| 6U0L | Q2N0S6 | Asymmetrically open conformational state (Class I) of HIV-1 Env trimer BG505 SOSIP.664 in complex with sCD4 and E51 Fab | |
| 6VO1 | Q2N0S6 | BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20J | Envelope glycoprotein gp120, Envelope glycoprotein gp41, RM20J Heavy chain Fab, RM20J Kappa light chain |
| 7KDE | Q2N0S6 | BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 interface antibody 8ANC195 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein gp120, Ab 1485 Heavy Chain, Ab 1485 Light Chain, 8ANC195 Fab Heavy Chain, 8ANC195 Fab Light Chain |
| 7LL1 | Q2N0S6 | Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibody VRC40.01 Fab | |
| 5THR | Q2N0S6 | Cryo-EM structure of a BG505 Env-sCD4-17b-8ANC195 complex | T-cell surface glycoprotein CD4, 17b Fab VH domain, BG505 SOSIP gp41 monomer, clade A/E 93TH057 HIV-1 gp120 core, 17b Fb VL domain, 8ANC195 G52K5 VH domain, 8ANC195 G52K5 VL domain |
| 6MN7 | Q2N0S6 | Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment | Envelope Glycoprotein gp120, Envelope Glycoprotein gp41, BF520.1 Fab variable region |
| 6MPH | Q2N0S6 | Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | DF1W-a.01 heavy chain, DF1W-a.01 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 heavy chain, PGT122 Light Chain, VRC03 Heavy chain, VRC03 Light Chain |
| 6MTJ | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
| 6VLR | Q2N0S6 | BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab | Envelope glycoprotein gp120, BG505 SOSIPv5.2 gp41, PGT122 Fab Heavy Chain, PGT122 Fab Light Chain, RM20E1 Fab Heavy Chain, RM20E1 Fab Kappa Chain |
| 5T3S | Q2N0S6 | HIV gp140 trimer MD39-10MUTA in complex with Fabs PGT124 and 35022 | |
| 5T3X | Q2N0S6 | 3.9 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trimer in Complex with the Broadly Neutralizing Antibodies IOMA and 10-1074. | |
| 5T3Z | Q2N0S6 | 3.5 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trimer in Complex with the Broadly Neutralizing Antibodies IOMA and 10-1074 | |
| 5UTF | Q2N0S6 | Crystal Structure of a Stabilized DS-SOSIP.6mut BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M in Complex with Human Antibodies PGT122 and 35O22 at 4.3 A | |
| 5UTY | Q2N0S6 | Crystal Structure of a Stabilized DS-SOSIP.mut4 BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, N300M, N302M, T320L in Complex with Human Antibodies PGT122 and 35O22 at 4.1 Angstrom | |
| 6CH7 | Q2N0S6 | XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | Envelope glycoprotein gp160, 35O22 Heavy Chain, 35O22 Light Chain, BG18 Heavy Chain, BG18 Light Chain |
| 6CH8 | Q2N0S6 | Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | |
| 6DFH | Q2N0S6 | BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding | Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain |
| 6DID | Q2N0S6 | HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 | Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain |
| 6OPA | Q2N0S6 | Crystal structure of bovine Fab NC-Cow1 in complex with HIV-1 BG505 SOSIP.664, and human Fabs 35022 and PGT128 | |
| 6OZC | Q2N0S6 | BG505 SOSIP.664 with 2G12 Fab2 | Envelope glycoprotein gp160, Envelope glycoprotein gp41, 2G12 Fab light chain, 2G12 Fab Heavy chain |
| 6PW6 | Q2N0S6 | The HIV-1 Envelope Glycoprotein Clone BG505 SOSIP.664 in Complex with Three Copies of the Bovine Broadly Neutralizing Antibody, NC-Cow1, Fragment Antigen Binding Domain | Envelope glycoprotein gp120, Envelope glycoprotein gp41, Broadly Neutralizing Antibody NC-Cow1 Heavy Chain |
| 6V6W | Q2N0S6 | Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 | |
| 6X9T | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9U | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9V | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6XRT | Q2N0S6 | Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 | Envelope glycoprotein gp41, BG505 gp120, VRC01.23 Light chain, VRC01.23 Heavy chain |
| 7LOK | Q2N0S6 | Structure of CD4 mimetic M48U1 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab | Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein BG505 SOSIP.664 gp120, 17b Fab Light Chain, 17b Fab Heavy Chain, M48U1 |
| 6CUE | Q2N0S6 | Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
